Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-024432
Filing Date
2016-08-15
Accepted
2016-08-15 17:26:41
Documents
55
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bind-10q_20160630.htm 10-Q 1434515
2 EX-31.1 bind-ex311_6.htm EX-31.1 21924
3 EX-32.1 bind-ex321_7.htm EX-32.1 8952
4 EX-99.1 bind-ex991_425.htm EX-99.1 821557
  Complete submission text file 0001564590-16-024432.txt   5176004

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bind-20160630.xml EX-101.INS 771269
6 XBRL TAXONOMY EXTENSION SCHEMA bind-20160630.xsd EX-101.SCH 35673
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bind-20160630_cal.xml EX-101.CAL 42941
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bind-20160630_def.xml EX-101.DEF 92250
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bind-20160630_lab.xml EX-101.LAB 259963
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bind-20160630_pre.xml EX-101.PRE 197040
Mailing Address 325 VASSAR STREET CAMBRIDGE MA 02139
Business Address 325 VASSAR STREET CAMBRIDGE MA 02139 6174913400
DNIB UNWIND, INC. (Filer) CIK: 0001385228 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36072 | Film No.: 161834079
SIC: 2834 Pharmaceutical Preparations